The Middle EAST Nasal Drug Delivery Market was valued at USD 1.2 billion in 2024 and is projected to reach USD 2.5 billion by 2034, registering a CAGR of 7.8%. This growth trajectory is underpinned by increasing consumer preference for non-invasive drug delivery methods, coupled with the rising prevalence of respiratory diseases and allergies. The nasal route offers rapid absorption and onset...